Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

PAVELKA Antonín VACEK Lukáš NOREK Adam KOBZOVÁ Šárka JANDA Lubomír

Year of publication 2024
Type Article in Periodical
Magazine / Source Biologia
MU Faculty or unit

Faculty of Science

Citation
Web https://link.springer.com/article/10.1007/s11756-023-01539-8
Doi http://dx.doi.org/10.1007/s11756-023-01539-8
Keywords LL-37; Secondary structure; Antibacterial activity; CD spectroscopy; GLL-37; Peptide
Description Antimicrobial peptides, including the human cathelicidin LL-37, offer a possible solution to the global problem of bacterial resistance to antibiotics. LL-37 peptide has potent antimicrobial effects against current multi-drug resistant bacterial strains. The peptide itself is also characterized by a very diverse range of immunomodulatory effects. The aim of this study was to produce antimicrobially active peptide LL-37 in E. coli in high yields using an own expression system pUbEx100 with the fusion protein ubiquitin. The results showed that the peptide GLL-37 could be produced in high amounts, but this peptide did not have antimicrobial activity compared to synthetically produced LL-37. CD spectroscopy results showed that the produced peptide GLL-37 is in ?-helix form in contrast to the sLL-37 (random-coil form). The recombinant peptide GLL-37 can not bind to the membrane in the ?-helix form, it would have to be in the form of a random-coil. This study confirms by CD spectroscopy the previously observed mechanism of access of LL-37 peptide to the bacterial membrane obtained by NMR.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.